Joint association of patients' sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers. - Li, Anlin; Chen, Yongjian; Zhang, Wenda; Zhong, Haitao; Ou, Qiyun; Gu, Yang; Xia, Junqing; Lin, Dagui; Fu, Tuping; Liu, Ruixin; Hu, Hai; Yu, Yunfang; et al. (Clinical & Translational Medicine, 2020)